salvinorin a has been researched along with Disease Models, Animal in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (83.33) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Chen, J; He, X; Ji, X; Liu, R; Ma, Y; Wu, D; Wu, L; Yao, T; Zhi, X | 1 |
Chen, D; Gao, ZQ; Liu, G; Liu, L; Pang, QF; Shan, JC; Su, Y; Wu, YX; Yuan, JN; Zeng, S; Zhu, T | 1 |
Dong, HP; He, ZZ; Ma, XX; Wang, ZH; Zhou, W | 1 |
Costa, EA; da Cunha, LC; Doerksen, RJ; Fajemiroye, JO; Keasling, AW; Pandey, P; Pedrino, GR; Zjawiony, JK | 1 |
Do Rego, JC; Fichna, J; Grzywacz, D; Kamysz, W; Polepally, PR; Sałaga, M; Sibaev, A; Sobczak, M; Storr, M; Zjawiony, JK | 1 |
Crippa, JA; dos Santos, RG; Hallak, JE; Machado-de-Sousa, JP | 1 |
He, Z; Wang, Z; Xin, J; Zhang, Y | 1 |
Abel, T; Chen, C; Liang, X; Liu, R; Ma, J; Su, D; Xi, C | 1 |
Butterweck, V; Phipps, SM | 1 |
Dicay, M; Fichna, J; Janecka, A; Lewellyn, K; MacNaughton, WK; Storr, MA; Zjawiony, JK | 1 |
Armstead, WM; Liu, R; Riley, J; Su, D | 1 |
Harden, MT; McCurdy, CR; Niehoff, JA; Smith, SE; Taylor, GT | 1 |
1 review(s) available for salvinorin a and Disease Models, Animal
Article | Year |
---|---|
Salvinorin a and related compounds as therapeutic drugs for psychostimulant-related disorders.
Topics: Amphetamine-Related Disorders; Analgesics, Opioid; Animals; Cocaine-Related Disorders; Disease Models, Animal; Diterpenes, Clerodane; Dopamine; Dopaminergic Neurons; Humans; Mexico; Receptors, Opioid, kappa; Salvia | 2014 |
11 other study(ies) available for salvinorin a and Disease Models, Animal
Article | Year |
---|---|
Intranasal salvinorin A improves neurological outcome in rhesus monkey ischemic stroke model using autologous blood clot.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Diterpenes, Clerodane; Infarction, Middle Cerebral Artery; Ischemic Stroke; Macaca mulatta; Magnetic Resonance Imaging; Male; Nervous System Diseases; Neuroprotective Agents; Treatment Outcome | 2021 |
Salvinorin A protects against methicillin resistant staphylococcus aureus-induced acute lung injury via Nrf2 pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Diterpenes, Clerodane; Inflammation Mediators; Lung; Macrophages; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; NF-E2-Related Factor 2; Oxidative Stress; Pneumonia, Staphylococcal; RAW 264.7 Cells; Signal Transduction | 2021 |
Salvinorin A preserves cerebral pial artery autoregulation after forebrain ischemia via the PI3K/AKT/cGMP pathway.
Topics: Animals; Brain Ischemia; Cerebral Arteries; Chromones; Cyclic GMP; Disease Models, Animal; Diterpenes, Clerodane; Male; Morpholines; Naltrexone; NG-Nitroarginine Methyl Ester; Phosphatidylinositol 3-Kinases; Pia Mater; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Salvindolin elicits opioid system-mediated antinociceptive and antidepressant-like activities.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Diterpenes, Clerodane; HEK293 Cells; Humans; Locomotion; Male; Mice; Models, Molecular; Pain; Receptors, Opioid, mu | 2019 |
Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome.
Topics: Abdominal Pain; Administration, Oral; Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Diarrhea; Disease Models, Animal; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Exploratory Behavior; Gastrointestinal Motility; Injections, Intraperitoneal; Irritable Bowel Syndrome; Male; Mice; Motor Activity; Naltrexone; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2014 |
Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats.
Topics: Animals; Aquaporin 4; Brain Injuries; Brain Ischemia; Cognition; Disease Models, Animal; Diterpenes, Clerodane; Male; Neuroprotective Agents; Prosencephalon; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reperfusion Injury | 2016 |
The Role of κ Opioid Receptor in Brain Ischemia.
Topics: Animals; Apoptosis; Blotting, Western; Brain Ischemia; Disease Models, Animal; Diterpenes, Clerodane; Male; Mice; Mice, Inbred C57BL; Naltrexone; Receptors, Opioid, kappa; Reperfusion Injury | 2016 |
A new digitized method of the compulsive gnawing test revealed dopaminergic activity of salvinorin A in vivo.
Topics: Analog-Digital Conversion; Animals; Behavior, Animal; Compulsive Behavior; Disease Models, Animal; Diterpenes, Clerodane; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mastication; Mice; Mice, Inbred C57BL; Motor Activity; Narcotic Antagonists; Plant Extracts; Receptors, Opioid, kappa; Salvia | 2010 |
Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Blotting, Western; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Diterpenes, Clerodane; Gastrointestinal Motility; Male; Mice; Naltrexone; Pain; Peroxidase; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, kappa; Salvia; Trinitrobenzenesulfonic Acid | 2012 |
Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxic/ischemic injury via extracellular signal-regulated kinase/mitogen-activated protein kinase in piglets.
Topics: Animals; Cerebrovascular Circulation; Disease Models, Animal; Diterpenes, Clerodane; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Homeostasis; Hypercapnia; Hypotension; Hypoxia-Ischemia, Brain; Pia Mater; Protein Kinase Inhibitors; Receptors, Opioid, kappa; Swine; Vasodilation; Vasodilator Agents | 2012 |
Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia.
Topics: Anhedonia; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Diterpenes, Clerodane; Female; Male; Motor Activity; Rats; Rats, Long-Evans; Receptors, Opioid, kappa; Salvia; Sucrose; Time Factors | 2012 |